Unleashing endogenous TNF-alpha as a cancer immunotherapeutic

Overview of attention for article published in Journal of Translational Medicine, August 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 6 news stories from 6 outlets.

SAN DIEGO (PRWEB) January 03, 2019 Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at the forefront of…

SAN DIEGO, Jan. 3, 2019 /PRNewswire-PRWeb/ -- Inc., a clinical‐stage biotechnology company at the forefront of oncolytic virus-ba…

The newly formed Scientific and Medical Advisory Board will enable Calidi Biotherapeutics to receive critical input and…

SAN DIEGO, Jan. 3, 2019 /PRNewswire-PRWeb/ -- Calidi Biotherapeutics, Inc., a clinical‐stage biotechnology company at the…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 2 additional news stories.